chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Feeling hot, Headache, Nausea
Clinical narrative: Dizzy; feel hot like crazy; chills; Bad headache; Nausea; Fever 100F; Felt like throwing up; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), FEELING HOT (feel hot like crazy), CHILLS (chills), HEADACHE (Bad headache) and NAUSEA (Nausea) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced DIZZINESS (Dizzy), FEELING HOT (feel hot like crazy), CHILLS (chills), HEADACHE (Bad headache), NAUSEA (Nausea), PYREXIA (Fever 100F) and VOMITING (Felt like throwing up). At the time of the report, DIZZINESS (Dizzy), FEELING HOT (feel hot like crazy), CHILLS (chills), HEADACHE (Bad headache), NAUSEA (Nausea), PYREXIA (Fever 100F) and VOMITING (Felt like throwing up) outcome was unknown. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.  No Relevant concomitant medications was reported.  Treatment information was not provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Dizzy; feel hot like crazy; chills; Bad headache; Nausea; Fever 100F; Felt like throwing up; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), FEELING HOT (feel hot like crazy), CHILLS (chills), HEADACHE (Bad headache) and NAUSEA (Nausea) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced DIZZINESS (Dizzy), FEELING HOT (feel hot like crazy), CHILLS (chills), HEADACHE (Bad headache), NAUSEA (Nausea), PYREXIA (Fever 100F) and VOMITING (Felt like throwing up). At the time of the report, DIZZINESS (Dizzy), FEELING HOT (feel hot like crazy), CHILLS (chills), HEADACHE (Bad headache), NAUSEA (Nausea), PYREXIA (Fever 100F) and VOMITING (Felt like throwing up) outcome was unknown. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.  No Relevant concomitant medications was reported.  Treatment information was not provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Rash
Clinical narrative: Red blotchy rash all over his back; Pretty bad skin rash mostly on my back and little bit on my chest; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red blotchy rash all over his back) and RASH (Pretty bad skin rash mostly on my back and little bit on my chest) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 007B21A) for COVID-19 vaccination.     The patient's past medical history included Lichen planus. Concurrent medical conditions included Neuropathy. Concomitant products included PREGABALIN (LYRICA) and GABAPENTIN for Neuropathy.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced ERYTHEMA (Red blotchy rash all over his back) and RASH (Pretty bad skin rash mostly on my back and little bit on my chest). At the time of the report, ERYTHEMA (Red blotchy rash all over his back) and RASH (Pretty bad skin rash mostly on my back and little bit on my chest) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the events was not Applicable.  Treatment information included skin cream.   This case was linked to MOD-2021-085633 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Additional information received  on 26-05-2021 included second dose batch number, concomitant medications, treatment medication and additional event was updated. On 20-Jul-2021: Follow up received on 20-JUL-2021 contains no significant information.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Vaccination site movement impairment, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: hurts to lift her arm; hot to the touch/warm; possibly was an allergic reaction to the vaccine; itchy; arm was swollen; rashy / really big rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (hurts to lift her arm), VACCINATION SITE WARMTH (hot to the touch/warm), ALLERGY TO VACCINE (possibly was an allergic reaction to the vaccine), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE SWELLING (arm was swollen) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (hurts to lift her arm), VACCINATION SITE WARMTH (hot to the touch/warm), ALLERGY TO VACCINE (possibly was an allergic reaction to the vaccine), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE RASH (rashy / really big rash). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (hurts to lift her arm), VACCINATION SITE WARMTH (hot to the touch/warm), ALLERGY TO VACCINE (possibly was an allergic reaction to the vaccine), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE RASH (rashy / really big rash) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Relevant concomitant product usage were not reported by the reporter. No treatment details were added.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up Information includes Patient Demographics, 2 nd dose Information and Events Outcome
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: hurts to lift her arm; hot to the touch/warm; possibly was an allergic reaction to the vaccine; itchy; arm was swollen; rashy / really big rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (hurts to lift her arm), VACCINATION SITE WARMTH (hot to the touch/warm), ALLERGY TO VACCINE (possibly was an allergic reaction to the vaccine), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE SWELLING (arm was swollen) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (hurts to lift her arm), VACCINATION SITE WARMTH (hot to the touch/warm), ALLERGY TO VACCINE (possibly was an allergic reaction to the vaccine), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE RASH (rashy / really big rash). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (hurts to lift her arm), VACCINATION SITE WARMTH (hot to the touch/warm), ALLERGY TO VACCINE (possibly was an allergic reaction to the vaccine), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE RASH (rashy / really big rash) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Relevant concomitant product usage were not reported by the reporter. No treatment details were added.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up Information includes Patient Demographics, 2 nd dose Information and Events Outcome
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: splitting headache; sore muscles; ran a temperature of 99.9 F for half a day or better; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (splitting headache), MYALGIA (sore muscles) and PYREXIA (ran a temperature of 99.9 F for half a day or better) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced HEADACHE (splitting headache), MYALGIA (sore muscles) and PYREXIA (ran a temperature of 99.9 F for half a day or better). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 21-Apr-2021, PYREXIA (ran a temperature of 99.9 F for half a day or better) had resolved. At the time of the report, HEADACHE (splitting headache) and MYALGIA (sore muscles) outcome was unknown.            Concomitant drugs were not reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-085661, US-MODERNATX, INC.-MOD-2021-086386, US-MODERNATX, INC.-MOD-2021-086668 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-085661: US-MODERNATX, INC.-MOD-2021-086668:wife case for 1 dose US-MODERNATX, INC.-MOD-2021-086386:father dose 2
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Bedridden, Body temperature, Diarrhoea, Pyrexia, Vision blurred
Clinical narrative: in bed for two days so he lost two days from work; diarrhea; 103 fever / still has the low grade fever for the past two weeks; blurry vision; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (in bed for two days so he lost two days from work), DIARRHOEA (diarrhea), VISION BLURRED (blurry vision) and PYREXIA (103 fever / still has the low grade fever for the past two weeks) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026AZ1A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced VISION BLURRED (blurry vision). On 09-Apr-2021, the patient experienced BEDRIDDEN (in bed for two days so he lost two days from work), DIARRHOEA (diarrhea) and PYREXIA (103 fever / still has the low grade fever for the past two weeks). On 09-Apr-2021, VISION BLURRED (blurry vision) had resolved. At the time of the report, BEDRIDDEN (in bed for two days so he lost two days from work) outcome was unknown and DIARRHOEA (diarrhea) and PYREXIA (103 fever / still has the low grade fever for the past two weeks) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Apr-2021, Body temperature: 103 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Significant follow up updated medication Clyndomycin  and Second dose added
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypersomnia, Nausea, Nervousness, Pain in extremity
Clinical narrative: jitterness; headache; nausea; slept all day and night; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), HYPERSOMNIA (slept all day and night), NERVOUSNESS (jitterness), HEADACHE (headache) and NAUSEA (nausea) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD.   On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 21-Apr-2021, the patient experienced HYPERSOMNIA (slept all day and night), HEADACHE (headache) and NAUSEA (nausea). On 22-Apr-2021, the patient experienced NERVOUSNESS (jitterness). At the time of the report, PAIN IN EXTREMITY (Sore arm), HYPERSOMNIA (slept all day and night), NERVOUSNESS (jitterness), HEADACHE (headache) and NAUSEA (nausea) outcome was unknown.            For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable. Treatment medication was not provided. concomitant product was not provided   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Follow-up information received on 02-JUN-2021 contains non-significant information.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Injection site pain, Myalgia, Nausea
Clinical narrative: soreness at the injection site; joint pain; nauseousness; headache; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), ARTHRALGIA (joint pain), MYALGIA (muscle pain), NAUSEA (nauseousness) and INJECTION SITE PAIN (soreness at the injection site) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced HEADACHE (headache) and MYALGIA (muscle pain). On 22-Apr-2021, the patient experienced ARTHRALGIA (joint pain) and NAUSEA (nauseousness). On an unknown date, the patient experienced INJECTION SITE PAIN (soreness at the injection site). At the time of the report, HEADACHE (headache), ARTHRALGIA (joint pain), MYALGIA (muscle pain), NAUSEA (nauseousness) and INJECTION SITE PAIN (soreness at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Vaccine leaked upon administration; Vaccine leaked upon administration; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Vaccine leaked upon administration) and DEVICE CONNECTION ISSUE (Vaccine leaked upon administration) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced UNDERDOSE (Vaccine leaked upon administration) and DEVICE CONNECTION ISSUE (Vaccine leaked upon administration). At the time of the report, UNDERDOSE (Vaccine leaked upon administration) and DEVICE CONNECTION ISSUE (Vaccine leaked upon administration) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient reported a potential cause as a syrinx in the follow up document.  No concomitant product was provided by the reporter. No treatment medications was provided  by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-086536 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Patient's ethnic group ,race , patient route of administration and expiration date of the suspect drug has been updated .Date of birth/age at vaccination has been amended from the Follow up document.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-086536:Crosllinked case
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash erythematous, Staphylococcal infection, Urticaria
Clinical narrative: Developed staph infection; 3 Quarter size red circles opposite arm of shot; itching like crazy; Hives; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Apr-2021 and was forwarded to Moderna on 22-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of STAPHYLOCOCCAL INFECTION (Developed staph infection), RASH ERYTHEMATOUS (3 Quarter size red circles opposite arm of shot), PRURITUS (itching like crazy) and URTICARIA (Hives) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced STAPHYLOCOCCAL INFECTION (Developed staph infection), RASH ERYTHEMATOUS (3 Quarter size red circles opposite arm of shot), PRURITUS (itching like crazy) and URTICARIA (Hives). At the time of the report, STAPHYLOCOCCAL INFECTION (Developed staph infection), RASH ERYTHEMATOUS (3 Quarter size red circles opposite arm of shot), PRURITUS (itching like crazy) and URTICARIA (Hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   This case was linked to MOD-2021-085731 (Patient Link).; Sender's Comments: based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
Age: 53.0
Sex: U
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: tested positive for Covid-19 infection; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for Covid-19 infection) in a 53-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 001C21A) for COVID-19 vaccination.     No medical history was not provided by reporter.  Concomitant products included METHOTREXATE, FOLIC ACID, calcium, MULTIVITAMIN [ASCORBIC ACID;BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINIC ACID;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE], CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), cranbberry pills and MILK THISTLE [SILYBUM MARIANUM] for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for Covid-19 infection). The patient was treated with ACETAMINOPHEN for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for Covid-19 infection) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Apr-2021, SARS-CoV-2 test positive: (Positive) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-085639 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Paraesthesia, Pruritus, Rash
Clinical narrative: tingling at the bottom of two toes on my left foot; stinging in my face; itchiness in my face; rash; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling at the bottom of two toes on my left foot), PAIN (stinging in my face), PRURITUS (itchiness in my face) and RASH (rash) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient experienced PARAESTHESIA (tingling at the bottom of two toes on my left foot), PAIN (stinging in my face), PRURITUS (itchiness in my face) and RASH (rash). The patient was treated with PREDNISONE at a dose of UNK dosage form. At the time of the report, PARAESTHESIA (tingling at the bottom of two toes on my left foot), PAIN (stinging in my face), PRURITUS (itchiness in my face) and RASH (rash) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Other treatment medication included hydrocortisone cream Action taken with mRNA-1273 in response to the event was not applicable
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: light headache; exhausted; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (light headache) and FATIGUE (exhausted) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (light headache) and FATIGUE (exhausted). At the time of the report, HEADACHE (light headache) and FATIGUE (exhausted) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.     This case was linked to MOD-2021-085741, MOD-2021-085741.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain
Clinical narrative: achy; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achy), CHILLS (chills) and HEADACHE (headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 029A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced PAIN (achy), CHILLS (chills) and HEADACHE (headache). At the time of the report, PAIN (achy), CHILLS (chills) and HEADACHE (headache) outcome was unknown.      The action taken with the mRNA-1273 is not applicable.     No Concomitant medications reported by the reporter. Treatment of these events were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: arm is like reddish where they gave me the shot and itchy; arm is like reddish where they gave me the shot and itchy; if she lays down in that side, it is sore; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (arm is like reddish where they gave me the shot and itchy), INJECTION SITE ERYTHEMA (arm is like reddish where they gave me the shot and itchy) and INJECTION SITE PAIN (if she lays down in that side, it is sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PRURITUS (arm is like reddish where they gave me the shot and itchy), INJECTION SITE ERYTHEMA (arm is like reddish where they gave me the shot and itchy) and INJECTION SITE PAIN (if she lays down in that side, it is sore). At the time of the report, INJECTION SITE PRURITUS (arm is like reddish where they gave me the shot and itchy), INJECTION SITE ERYTHEMA (arm is like reddish where they gave me the shot and itchy) and INJECTION SITE PAIN (if she lays down in that side, it is sore) outcome was unknown.            No concomitant and treatment medications were reported. For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for COVID-19) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID-19). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.Treatment medication was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Product administered at inappropriate site
Clinical narrative: Band aid where shot was , was located far back on shoulder, concerned shot was given in the wrong location; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Band aid where shot was , was located far back on shoulder, concerned shot was given in the wrong location) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A214) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) and SALBUTAMOL SULFATE (INHALERIN) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Band aid where shot was , was located far back on shoulder, concerned shot was given in the wrong location). At the time of the report, PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Band aid where shot was , was located far back on shoulder, concerned shot was given in the wrong location) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details were not reported   This case was linked to MOD21-080680 (E2B Linked Report).; Sender's Comments:  MOD21-080680:Wife's case
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Decreased appetite, Headache, Malaise
Clinical narrative: equilibrium lost; lost of appetite; Badly Sick; pounding head ache; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (equilibrium lost), DECREASED APPETITE (lost of appetite), MALAISE (Badly Sick) and HEADACHE (pounding head ache) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 046B21A) for COVID-19 vaccination.     No medical history was provided by the reporte.  Concomitant products included MULTI VITAMIN & MINERAL, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12), VITAMIN D3, CHOLESTEROL, SIMVASTATIN (BESTATIN [SIMVASTATIN]), RIVAROXABAN (XARELTO), POTASSIUM, FOLIC ACID and LOSARTAN for an unknown indication.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced BALANCE DISORDER (equilibrium lost), DECREASED APPETITE (lost of appetite), MALAISE (Badly Sick) and HEADACHE (pounding head ache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 milligram. At the time of the report, BALANCE DISORDER (equilibrium lost), DECREASED APPETITE (lost of appetite), MALAISE (Badly Sick) and HEADACHE (pounding head ache) had not resolved.            Treatment medication included Tylenol 500 mg and Aleve 200 mg one for every 12 hours   This case was linked to US-MODERNATX, INC.-MOD-2021-085746 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-085746:Second dose case for same reporter patient
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: sore arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and HEADACHE (headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and HEADACHE. On 16-Jan-2021, PAIN IN EXTREMITY (sore arm) and HEADACHE had resolved.            No concomitant drug information was provided. No treatment information was provided.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Product temperature excursion issue
Clinical narrative: first vaccine dose from batch suspected by temperature excursion; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (first vaccine dose from batch suspected by temperature excursion) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (first vaccine dose from batch suspected by temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (first vaccine dose from batch suspected by temperature excursion) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications includes Birth control tablets. No treatment drugs were reported.   This case was linked to MOD-2021-085693 (E2B Linked Report).; Sender's Comments:  MOD-2021-085693:Husband case
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: 3 Quarter size red circles opposite arm of shot; Itching like crazy; hives; This spontaneous case was reported by a consumer and describes the occurrence of RASH (3 Quarter size red circles opposite arm of shot), PRURITUS (Itching like crazy) and URTICARIA (hives) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (3 Quarter size red circles opposite arm of shot), PRURITUS (Itching like crazy) and URTICARIA (hives). At the time of the report, RASH (3 Quarter size red circles opposite arm of shot), PRURITUS (Itching like crazy) and URTICARIA (hives) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   .   This case was linked to MOD-2021-085686 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Dry eye, Dysstasia, Feeling hot
Clinical narrative: when she was trying to stand up she thought that she was going to collapse; "horrible rocking chills that won't stop; Headache; Ran a fever; severe tenderness in arm where she got vaccine; Pain in arm where she got the vaccine; Sick on her stomach; felt hot; sore throat; Dry eyes; hard time to focus; was debilitated for 2 days, felt wobbly; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (severe tenderness in arm where she got vaccine), PAIN IN EXTREMITY (Pain in arm where she got the vaccine), ABDOMINAL DISCOMFORT (Sick on her stomach), FEELING HOT (felt hot) and OROPHARYNGEAL PAIN (sore throat) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 008B21-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in October 2020.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced TENDERNESS (severe tenderness in arm where she got vaccine), PAIN IN EXTREMITY (Pain in arm where she got the vaccine), ABDOMINAL DISCOMFORT (Sick on her stomach), FEELING HOT (felt hot), OROPHARYNGEAL PAIN (sore throat), DRY EYE (Dry eyes), VISION BLURRED (hard time to focus), MALAISE (was debilitated for 2 days, felt wobbly), CHILLS ("horrible rocking chills that won't stop), HEADACHE (Headache) and PYREXIA (Ran a fever). On 21-Apr-2021, the patient experienced DYSSTASIA (when she was trying to stand up she thought that she was going to collapse). On 21-Apr-2021, DYSSTASIA (when she was trying to stand up she thought that she was going to collapse) outcome was unknown. On 22-Apr-2021, MALAISE (was debilitated for 2 days, felt wobbly) outcome was unknown. At the time of the report, TENDERNESS (severe tenderness in arm where she got vaccine), PAIN IN EXTREMITY (Pain in arm where she got the vaccine), ABDOMINAL DISCOMFORT (Sick on her stomach), FEELING HOT (felt hot), OROPHARYNGEAL PAIN (sore throat), DRY EYE (Dry eyes), VISION BLURRED (hard time to focus), CHILLS ("horrible rocking chills that won't stop), HEADACHE (Headache) and PYREXIA (Ran a fever) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Malaise, Oropharyngeal pain, Pain in extremity, Pyrexia
Clinical narrative: when she was trying to stand up she thought that she was going to collapse; "horrible rocking chills that won't stop; Headache; Ran a fever; severe tenderness in arm where she got vaccine; Pain in arm where she got the vaccine; Sick on her stomach; felt hot; sore throat; Dry eyes; hard time to focus; was debilitated for 2 days, felt wobbly; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (severe tenderness in arm where she got vaccine), PAIN IN EXTREMITY (Pain in arm where she got the vaccine), ABDOMINAL DISCOMFORT (Sick on her stomach), FEELING HOT (felt hot) and OROPHARYNGEAL PAIN (sore throat) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 008B21-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in October 2020.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced TENDERNESS (severe tenderness in arm where she got vaccine), PAIN IN EXTREMITY (Pain in arm where she got the vaccine), ABDOMINAL DISCOMFORT (Sick on her stomach), FEELING HOT (felt hot), OROPHARYNGEAL PAIN (sore throat), DRY EYE (Dry eyes), VISION BLURRED (hard time to focus), MALAISE (was debilitated for 2 days, felt wobbly), CHILLS ("horrible rocking chills that won't stop), HEADACHE (Headache) and PYREXIA (Ran a fever). On 21-Apr-2021, the patient experienced DYSSTASIA (when she was trying to stand up she thought that she was going to collapse). On 21-Apr-2021, DYSSTASIA (when she was trying to stand up she thought that she was going to collapse) outcome was unknown. On 22-Apr-2021, MALAISE (was debilitated for 2 days, felt wobbly) outcome was unknown. At the time of the report, TENDERNESS (severe tenderness in arm where she got vaccine), PAIN IN EXTREMITY (Pain in arm where she got the vaccine), ABDOMINAL DISCOMFORT (Sick on her stomach), FEELING HOT (felt hot), OROPHARYNGEAL PAIN (sore throat), DRY EYE (Dry eyes), VISION BLURRED (hard time to focus), CHILLS ("horrible rocking chills that won't stop), HEADACHE (Headache) and PYREXIA (Ran a fever) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness, Vision blurred
Clinical narrative: when she was trying to stand up she thought that she was going to collapse; "horrible rocking chills that won't stop; Headache; Ran a fever; severe tenderness in arm where she got vaccine; Pain in arm where she got the vaccine; Sick on her stomach; felt hot; sore throat; Dry eyes; hard time to focus; was debilitated for 2 days, felt wobbly; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (severe tenderness in arm where she got vaccine), PAIN IN EXTREMITY (Pain in arm where she got the vaccine), ABDOMINAL DISCOMFORT (Sick on her stomach), FEELING HOT (felt hot) and OROPHARYNGEAL PAIN (sore throat) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 008B21-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in October 2020.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced TENDERNESS (severe tenderness in arm where she got vaccine), PAIN IN EXTREMITY (Pain in arm where she got the vaccine), ABDOMINAL DISCOMFORT (Sick on her stomach), FEELING HOT (felt hot), OROPHARYNGEAL PAIN (sore throat), DRY EYE (Dry eyes), VISION BLURRED (hard time to focus), MALAISE (was debilitated for 2 days, felt wobbly), CHILLS ("horrible rocking chills that won't stop), HEADACHE (Headache) and PYREXIA (Ran a fever). On 21-Apr-2021, the patient experienced DYSSTASIA (when she was trying to stand up she thought that she was going to collapse). On 21-Apr-2021, DYSSTASIA (when she was trying to stand up she thought that she was going to collapse) outcome was unknown. On 22-Apr-2021, MALAISE (was debilitated for 2 days, felt wobbly) outcome was unknown. At the time of the report, TENDERNESS (severe tenderness in arm where she got vaccine), PAIN IN EXTREMITY (Pain in arm where she got the vaccine), ABDOMINAL DISCOMFORT (Sick on her stomach), FEELING HOT (felt hot), OROPHARYNGEAL PAIN (sore throat), DRY EYE (Dry eyes), VISION BLURRED (hard time to focus), CHILLS ("horrible rocking chills that won't stop), HEADACHE (Headache) and PYREXIA (Ran a fever) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Taste disorder, Vaccination site rash
Clinical narrative: Blotch dots on rash; Rash around injection site/Rash is smooth; Taste of coffee and all drinks and food "odd","funny taste", "yucky; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (Taste of coffee and all drinks and food "odd","funny taste", "yucky), RASH MACULAR (Blotch dots on rash) and VACCINATION SITE RASH (Rash around injection site/Rash is smooth) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced TASTE DISORDER (Taste of coffee and all drinks and food "odd","funny taste", "yucky). On 30-Apr-2021, the patient experienced RASH MACULAR (Blotch dots on rash) and VACCINATION SITE RASH (Rash around injection site/Rash is smooth). At the time of the report, TASTE DISORDER (Taste of coffee and all drinks and food "odd","funny taste", "yucky), RASH MACULAR (Blotch dots on rash) and VACCINATION SITE RASH (Rash around injection site/Rash is smooth) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medication provided   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up received on 30-APR-2021. New events added
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Chills, Lymphadenopathy, Myalgia, Nausea
Clinical narrative: experienced every possible side effect; Pain in chest; pain in arm, legs and feet; swollen underneath his left armpit area; Fever; nausea; Chills; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), NAUSEA (nausea), CHILLS (Chills), MYALGIA (Muscle pain) and VACCINATION COMPLICATION (experienced every possible side effect) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced CHILLS (Chills) and MYALGIA (Muscle pain). On 21-Apr-2021, the patient experienced PYREXIA (Fever), NAUSEA (nausea) and LYMPHADENOPATHY (swollen underneath his left armpit area). On 22-Apr-2021, the patient experienced CHEST PAIN (Pain in chest) and PAIN IN EXTREMITY (pain in arm, legs and feet). On an unknown date, the patient experienced VACCINATION COMPLICATION (experienced every possible side effect). At the time of the report, PYREXIA (Fever), NAUSEA (nausea), CHILLS (Chills), MYALGIA (Muscle pain), VACCINATION COMPLICATION (experienced every possible side effect), LYMPHADENOPATHY (swollen underneath his left armpit area), CHEST PAIN (Pain in chest) and PAIN IN EXTREMITY (pain in arm, legs and feet) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Vaccination complication
Clinical narrative: experienced every possible side effect; Pain in chest; pain in arm, legs and feet; swollen underneath his left armpit area; Fever; nausea; Chills; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), NAUSEA (nausea), CHILLS (Chills), MYALGIA (Muscle pain) and VACCINATION COMPLICATION (experienced every possible side effect) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced CHILLS (Chills) and MYALGIA (Muscle pain). On 21-Apr-2021, the patient experienced PYREXIA (Fever), NAUSEA (nausea) and LYMPHADENOPATHY (swollen underneath his left armpit area). On 22-Apr-2021, the patient experienced CHEST PAIN (Pain in chest) and PAIN IN EXTREMITY (pain in arm, legs and feet). On an unknown date, the patient experienced VACCINATION COMPLICATION (experienced every possible side effect). At the time of the report, PYREXIA (Fever), NAUSEA (nausea), CHILLS (Chills), MYALGIA (Muscle pain), VACCINATION COMPLICATION (experienced every possible side effect), LYMPHADENOPATHY (swollen underneath his left armpit area), CHEST PAIN (Pain in chest) and PAIN IN EXTREMITY (pain in arm, legs and feet) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.